春立医疗
(688236)
| 流通市值：10.97亿 | | | 总市值：53.09亿 |
| 流通股本：7929.47万 | | | 总股本：3.84亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 508,283,661.62 | 380,130,570.92 | 221,850,180.79 | 1,208,523,845.88 |
| 营业收入 | 508,283,661.62 | 380,130,570.92 | 221,850,180.79 | 1,208,523,845.88 |
| 二、营业总成本 | 449,469,327.29 | 304,028,844.65 | 164,450,441.62 | 911,961,036.54 |
| 营业成本 | 156,043,170.05 | 108,247,815.46 | 58,041,719.59 | 332,635,741.48 |
| 税金及附加 | 6,012,961.59 | 4,342,874.75 | 1,832,378.18 | 10,850,629.27 |
| 销售费用 | 163,464,944.14 | 111,481,168.8 | 63,145,976.61 | 383,140,145.99 |
| 管理费用 | 31,357,332.9 | 21,310,062.04 | 7,522,645.72 | 44,471,023.1 |
| 研发费用 | 99,676,406.7 | 67,659,413.06 | 34,991,868.71 | 157,445,504.26 |
| 财务费用 | -7,085,488.09 | -9,012,489.46 | -1,084,147.19 | -16,582,007.56 |
| 其中:利息费用 | 27,847.25 | 27,050.23 | - | 85,896.45 |
| 其中:利息收入 | 8,960,596.25 | 8,040,034.97 | 1,263,505.11 | 14,461,912.36 |
| 加:公允价值变动收益 | 6,079,575.33 | 4,670,205.47 | 1,380,799.84 | 9,610,896.66 |
| 加:投资收益 | 9,122,896.79 | 6,084,909.58 | 3,286,525.21 | 12,012,452.06 |
| 资产处置收益 | 39,213.61 | 39,213.61 | - | 3,904.6 |
| 资产减值损失(新) | -9,409,707.93 | -5,229,285.17 | -26,245.26 | -20,707,206.43 |
| 信用减值损失(新) | -7,060,926.86 | -5,794,060.61 | -5,451,806.83 | -4,315,237.96 |
| 其他收益 | 7,865,268.9 | 6,413,483.27 | 2,736,455.16 | 12,807,845.26 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 65,450,654.17 | 82,286,192.42 | 59,325,467.29 | 305,975,463.53 |
| 加:营业外收入 | 870,286.2 | 856,684.38 | 856,134.36 | 346,862.92 |
| 减:营业外支出 | 156,306.21 | 72,914.25 | 17,033 | 416,463.41 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 66,164,634.16 | 83,069,962.55 | 60,164,568.65 | 305,905,863.04 |
| 减:所得税费用 | 5,155,985.69 | 4,109,067.77 | 5,057,505.44 | 28,087,746.56 |
| 六、净利润 | 61,008,648.47 | 78,960,894.78 | 55,107,063.21 | 277,818,116.48 |
| 持续经营净利润 | 61,008,648.47 | 78,960,894.78 | 55,107,063.21 | 277,818,116.48 |
| 归属于母公司股东的净利润 | 61,151,445.55 | 79,026,078.82 | 55,199,616.28 | 277,824,014.12 |
| 少数股东损益 | -142,797.08 | -65,184.04 | -92,553.07 | -5,897.64 |
| (一)基本每股收益 | 0.16 | 0.21 | 0.14 | 0.72 |
| (二)稀释每股收益 | 0.16 | 0.21 | 0.14 | 0.72 |
| 九、综合收益总额 | 61,008,648.47 | 78,960,894.78 | 55,107,063.21 | 277,818,116.48 |
| 归属于母公司股东的综合收益总额 | 61,151,445.55 | 79,026,078.82 | 55,199,616.28 | 277,824,014.12 |
| 归属于少数股东的综合收益总额 | -142,797.08 | -65,184.04 | -92,553.07 | -5,897.64 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |